Imprifab SRL
The score of Imprifab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +200 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Imprifab's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 16 Aug 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Imprifab's financial analysis
- Solvency-73.2%sector median: 52.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Imprifab
Imprifab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0812.337.386
- VAT number
- BE0812337386
- Peppol
- Registered · 0208:0812337386 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Jun 2009
- Registered office
- 9940 Evergem
- Latest accounts
- 2025 · filed on 17 Aug 2026
- Activity
- Manufacture of other chemical products n.e.c. (NACE 20590)
Imprifab (SRL) has been based in Evergem since 2009, active in: manufacture of other chemical products n.e.c.. For 2025, it reports a net profit of 1,802 € and equity of −9,130 €; its revenue is not published. Its solvency stands at -73.2%, below the median of its sector (52.9%).
Companies similar to Imprifab
Companies in the same business, of comparable size and area, outside its group.
- Vibek Manufacture of other chemical products n.e.c. Wuustwezel · balance sheet 24,530 €
- Bad Ass Industries Manufacture of other chemical products n.e.c. Maaseik · balance sheet 39,398 €
- Maria De Dauw Manufacture of other chemical products n.e.c. Antwerp · balance sheet 9,095 €
- Greenseal Manufacture of other chemical products n.e.c. Sint-Martens-Latem · balance sheet 58,298 €
- Aethera Manufacture of other chemical products n.e.c. Tubize · balance sheet 41,928 €
- Heatcover Manufacture of other chemical products n.e.c. Stekene · balance sheet 62,446 €
- Assistance and Service Office Continental Manufacture of other chemical products n.e.c. Roeselare · balance sheet 74,443 €
- Cosmashop Manufacture of other chemical products n.e.c. Uccle · balance sheet 39,165 €
Frequently asked questions about Imprifab
What is the revenue of Imprifab?
Imprifab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Imprifab?
In Belgium, the VAT number is the company number prefixed with BE: BE0812337386 for Imprifab, if the company is VAT-registered. Its company number (CBE) is 0812.337.386.
Where is the registered office of Imprifab?
According to the CBE register, the registered office of Imprifab is in 9940 Evergem.
What is the equity of Imprifab?
At the close of the 2025 financial year, the equity of Imprifab amounts to -9,130 €, a solvency of -73.2% of total assets.
Who manages Imprifab?
The register lists 1 active mandates at Imprifab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Imprifab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →